These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 9179184

  • 1. Growth factors mediate glucocorticoid receptor function and dexamethasone-induced regression of osteoblastic lesions in hormone refractory prostate cancer.
    Koutsilieris M, Reyes-Moreno C, Sourla A, Dimitriadou V, Choki I.
    Anticancer Res; 1997; 17(3A):1461-5. PubMed ID: 9179184
    [Abstract] [Full Text] [Related]

  • 2. Glucocorticoid receptor function possibly modulates cell-cell interactions in osteoblastic metastases on rat skeleton.
    Reyes-Moreno C, Koutsilieris M.
    Clin Exp Metastasis; 1997 May; 15(3):205-17. PubMed ID: 9174122
    [Abstract] [Full Text] [Related]

  • 3. Human prostatic tumor cells in culture produce growth and differentiation factors active on osteoblasts: a new biological and clinical parameter for prostatic carcinoma.
    Festuccia C, Teti A, Bianco P, Guerra F, Vicentini C, Tennina R, Villanova I, Sciortino G, Bologna M.
    Oncol Res; 1997 May; 9(8):419-31. PubMed ID: 9436195
    [Abstract] [Full Text] [Related]

  • 4. Transforming growth factor beta inhibits plasminogen activator (PA) activity and stimulates production of urokinase-type PA, PA inhibitor-1 mRNA, and protein in rat osteoblast-like cells.
    Allan EH, Zeheb R, Gelehrter TD, Heaton JH, Fukumoto S, Yee JA, Martin TJ.
    J Cell Physiol; 1991 Oct; 149(1):34-43. PubMed ID: 1834680
    [Abstract] [Full Text] [Related]

  • 5. Glucocorticoid receptor function suppresses insulin-like growth factor 1 activity in human KLE endometrial-like cells.
    Lembessis P, Kalariti N, Koutsilieris M.
    In Vivo; 2004 Oct; 18(1):43-7. PubMed ID: 15011750
    [Abstract] [Full Text] [Related]

  • 6. Osteoblast-derived growth factors enhance adriamycin-cytostasis of MCF-7 human breast cancer cells.
    Choki I, Sourla A, Reyes-Moreno C, Koutsilieris M.
    Anticancer Res; 1998 Oct; 18(6A):4213-24. PubMed ID: 9891470
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Three-dimensional type I collagen gel system for the study of osteoblastic metastases produced by metastatic prostate cancer.
    Koutsilieris M, Sourla A, Pelletier G, Doillon CJ.
    J Bone Miner Res; 1994 Nov; 9(11):1823-32. PubMed ID: 7863832
    [Abstract] [Full Text] [Related]

  • 13. PA-III rat prostate adenocarcinoma cells (review).
    Koutsilieris M.
    In Vivo; 1992 Nov; 6(2):199-203. PubMed ID: 1326342
    [Abstract] [Full Text] [Related]

  • 14. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
    Bauer TW, Liu W, Fan F, Camp ER, Yang A, Somcio RJ, Bucana CD, Callahan J, Parry GC, Evans DB, Boyd DD, Mazar AP, Ellis LM.
    Cancer Res; 2005 Sep 01; 65(17):7775-81. PubMed ID: 16140945
    [Abstract] [Full Text] [Related]

  • 15. Bone-related growth factors and zoledronic acid regulate the PTHrP/PTH.1 receptor bioregulation systems in MG-63 human osteosarcoma cells.
    Tenta R, Sourla A, Lembessis P, Koutsilieris M.
    Anticancer Res; 2006 Sep 01; 26(1A):283-91. PubMed ID: 16475708
    [Abstract] [Full Text] [Related]

  • 16. Insulin-like growth factor (IGF) I down-regulates type 1 IGF receptor (IGF 1R) and reduces the IGF I response in A549 non-small-cell lung cancer and Saos-2/B-10 osteoblastic osteosarcoma cells.
    Bostedt KT, Schmid C, Ghirlanda-Keller C, Olie R, Winterhalter KH, Zapf J.
    Exp Cell Res; 2001 Dec 10; 271(2):368-77. PubMed ID: 11716549
    [Abstract] [Full Text] [Related]

  • 17. MG-63 osteoblast-like cells enhance the osteoprotegerin expression of PC-3 prostate cancer cells.
    Katopodis H, Philippou A, Tenta R, Doillon C, Papachroni KK, Papavassiliou AG, Koutsilieris M.
    Anticancer Res; 2009 Oct 10; 29(10):4013-8. PubMed ID: 19846944
    [Abstract] [Full Text] [Related]

  • 18. Tranilast inhibits hormone refractory prostate cancer cell proliferation and suppresses transforming growth factor beta1-associated osteoblastic changes.
    Izumi K, Mizokami A, Li YQ, Narimoto K, Sugimoto K, Kadono Y, Kitagawa Y, Konaka H, Koh E, Keller ET, Namiki M.
    Prostate; 2009 Aug 01; 69(11):1222-34. PubMed ID: 19434660
    [Abstract] [Full Text] [Related]

  • 19. Beta-2 microglobulin is mitogenic to PC-3 prostatic carcinoma cells and antagonistic to transforming growth factor beta 1 action.
    Rowley DR, Dang TD, McBride L, Gerdes MJ, Lu B, Larsen M.
    Cancer Res; 1995 Feb 15; 55(4):781-6. PubMed ID: 7850789
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.